Nova Eye USA Sales Growth Opportunity slide image

Nova Eye USA Sales Growth Opportunity

Reimbursement for Nova Eye Products in the USA Product Facility Fee for applicable surgery for 2024 (US$) Physician Fee for applicable surgery for 2024 (US$) HOPD ASC iTrack Advance for canaloplasty surgery $3,877 $2,045 $607 Molteno3 Glaucoma Drainage device $2,222 $1,183 $828 • Fees set and reviewed annually by CMS • Differential product pricing to HOPD and ASC • • Nova Eye invoices the Facility and the product price is paid from the Facility fee Payments against a particular CMS code by MACs can change from time to time. with the issue of a new "Local Coverage Determination (LCD)" ne nova-eye.com | 29
View entire presentation